Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03711604
Title Compassionate Use Study of Tenalisib (RP6530)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rhizen Pharmaceuticals SA
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Hellen Diller Family Comprehensive Cancer Center San Francisco California 94143 United States Details
Division of Hematology, University of Colorado, Denver Colorado 80045 United States Details
Cleveland Clinic Taussig Cancer Institute Cleveland Ohio 44195 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Ltd. M.Zodelava Hematology Centre Tbilisi Georgia Details
Medivest - Institute of Hematology and Transfusiology Tbilisi Georgia Details
Silesian Healthy Blood Clinic Grosicki, Grosicka Sp.J. Chorzów 41-503 Poland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field